CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. The purpose of this amendment is to modify the other licensed practitioner benefit to allow licensed pharmacists within their state scope of practice with CLIA waiver certification to provide diagnostic COVID-19 antigen tests; and to reimburse pharmacists providing COVID testing using a state-developed fee schedule for diagnostic testing.
State
Approval Date
Effective Date
File 1 - Approval Document Media